English | Español
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
Patient Daily | Apr 8, 2026

National Breathe Free highlights community involvement alongside clinical care
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
Patient Daily | Apr 7, 2026

FDA proposes new clinical trial pathway to accelerate drug development timelines
Patient Daily | Apr 6, 2026

FDA reversals on external controls in rare disease trials raise questions for drug developers
Patient Daily | Apr 6, 2026

Study links lack of affordable dental care to higher risk of heart disease and dementia
Patient Daily | Apr 6, 2026

High-dose flu vaccine linked to lower Alzheimer’s disease risk
Patient Daily | Apr 6, 2026

Gene-edited treatment shows promising outcomes for severe sickle cell disease

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Pharmaceuticals
Patient Daily | Apr 6, 2026

FDA reversals on external controls in rare disease trials raise questions for drug developers
Patient Daily | Apr 7, 2026

FDA proposes new clinical trial pathway to accelerate drug development timelines